|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09887 LEADS BIOLABS-B
Nominal 
92.000 +0.300 (+0.327%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 |
| Property, plant, equip. & others | 29,323 | -19.394% | 36,378 | 54,282 |
| Land & other Lease Assets | 19,692 | 75.994% | 11,189 | 6,812 |
| Intangible Assets | 1,758 | -- | 0 | 0 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 |
| Other Non-current Assets | 40,419 | 58.078% | 25,569 | 19,267 |
| 91,192 | 24.688% | 73,136 | 80,361 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||
| Inventories | 58,016 | -- | 0 | 0 | |
| Trade Receivables | 0 | -- | 0 | 0 | |
| Cash & Bank Balances | 1,221,150 | 227.789% | 372,542 | 247,523 | |
| Other Current Assets | 411,061 | 83.702% | 223,765 | 119,598 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | |
| 1,690,227 | 183.449% | 596,307 | 367,121 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |||
| Trade Payables | 6,490 | 84.166% | 3,524 | 215 | ||
| S-T Debt & Leases | 267,159 | 2.388% | 260,928 | 65,311 | ||
| Other Current Liabilities | 228,555 | 70.711% | 133,884 | 1,328,984 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | ||
| 502,204 | 26.075% | 398,336 | 1,394,510 | |||
| Net Current Assets | 1,188,023 | 500.100% | 197,971 | (1,027,389) | ||
| Total Assets Less Current Liabilities | 1,279,215 | 371.849% | 271,107 | (947,028) | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||||
| L-T Debt & Leases | 13,401 | 141.590% | 5,547 | 1,777 | |||
| Other Non-current Liabilities | 0 | -- | 0 | 0 | |||
| 13,401 | 141.590% | 5,547 | 1,777 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |||||
| Share Capital | 198,892 | 27.088% | 156,500 | 17,018 | ||||
| Reserves | 1,066,922 | 878.289% | 109,060 | (965,823) | ||||
| Others | 0 | -- | 0 | 0 | ||||
| Shareholders' Funds | 1,265,814 | 376.658% | 265,560 | (948,805) | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| 1,265,814 | 376.658% | 265,560 | (948,805) | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Commitments | -- | -- | 143 | 1,057 |
| Contingent Liabilities | -- | -- | 0 | 0 |
| Remarks: | Real time quote last updated: 10/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -211,419 |
| %Change | -29.811% |
| EPS / (LPS) | RMB -1.210 |
| NBV Per Share (¥) | RMB 6.364 |